Stocks / Stock overview
Cme Group Inc. (CME)
Quote, stock score, analyst consensus, and SEC filings, plus insider and Congress trades when there are any.
Aft $309.09 (+0.00%)
NasdaqGS · Price as of · Delayed Quote
Stock Scorer
Scoring…
Analyst consensus
$317.06
- Analysts16
- Implied upside+2.6%
- Target range$227.00 to $367.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Congress trades in CME
| Date | Member | Action | Amount | |
|---|---|---|---|---|
| 2026-06-16 | Gil Cisneros CA | Sale (Partial) | $1,001 - $15,000 | |
| 2026-03-27 | Alan Armstrong OK | Purchase | $1,001 - $15,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | November 10, 2026 | FORM 4 |
| 144 | November 9, 2026 | View on EDGAR |
| 4 | November 3, 2026 | FORM 4 |
| 4 | November 2, 2026 | FORM 4 |
| 3 | November 2, 2026 | FORM 3 |
| 144 | November 2, 2026 | View on EDGAR |
| 144 | November 2, 2026 | View on EDGAR |
| 4 | October 27, 2026 | FORM 4 |
CME news
Frequently asked questions
What do analysts expect for CME?
16 analysts cover Cme Group Inc. (CME). The consensus rating is Buy. The average price target is $317.06, in a range of $227.00 to $367.00.
Are insiders buying or selling CME?
We have no qualifying Form 4 insider purchases or sales on record for Cme Group Inc. (CME). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see CME SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed November 10, 2026.
Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.